New Disposable VUSE GO 5000 and VUSE GO 6000 Launched

InnovationVUSE by 2FIRSTS.ai
Nov.23.2023
New Disposable VUSE GO 5000 and VUSE GO 6000 Launched
VUSE recently launched "VUSE GO 5000" and "VUSE GO 6000" disposable products in the Middle East market.

On November 23, 2FIRSTS, a popular vaping brand, discovered that VUSE has launched new disposable products called "VUSE GO 5000" and "VUSE GO 6000" in the Middle East market. These products come in high nicotine content variants, with the "VUSE GO 5000" offering 5000 puffs and the "VUSE GO 6000" offering 6000 puffs.

New Disposable VUSE GO 5000 and VUSE GO 6000 Launched
The product "VUSE GO 6000" sold on the VUSE official website | Image source: VUSE

 

These two products each come in 5 different flavors, namely mango ice, grape ice, blueberry ice, mint ice, and blue raspberry.

New Disposable VUSE GO 5000 and VUSE GO 6000 Launched
The product "VUSE GO 5000" is sold on the official VUSE website. Image source: VUSE.

 

The official retail price of VUSE GO 5000 is 80 dirhams, equivalent to approximately 155 Chinese yuan.

 

Previously, 2FIRSTS conducted market research in Russia and found that VUSE had launched a product with a range of 5000 puffs in that market, with a retail price of 1300 Russian rubles, approximately 95 Chinese yuan, which was 60 Chinese yuan lower than the official VUSE website in the Middle East.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris International and Swedish Match Win Collective Lawsuit Over Zyn Nicotine Pouches
Philip Morris International and Swedish Match Win Collective Lawsuit Over Zyn Nicotine Pouches
In a recent victory, Philip Morris International and Swedish Match won a lawsuit concerning their product Zyn's pricing.
Sep.25 by 2FIRSTS.ai
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s new nicotine pouch On! PLUS™ is slated to launch in the U.S. on October 14, debuting in North Carolina, Texas, and Florida. The product uses NICOSILK™ technology and will offer multiple nicotine strengths. FDA approval has not yet been granted, but Helix says it is proceeding in line with compliance requirements.
Oct.11 by 2FIRSTS.ai
Leaked EU Paper Suggests COP11 Push to Ban Nicotine Pouches and Flavoured Nicotine Products
Leaked EU Paper Suggests COP11 Push to Ban Nicotine Pouches and Flavoured Nicotine Products
According to media reports, a leaked European Commission document indicates the EU plans to push for its strictest regulatory framework on nicotine and tobacco products at COP11 in Switzerland this November, including measures such as a full ban on nicotine pouches and flavoured products.
Oct.10 by 2FIRSTS.ai
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.
Oct.23 by 2FIRSTS.ai
Spain to Tighten E-Cigarette Regulation: Public-Place Ban, Advertising Limits, Flavour Controls
Spain to Tighten E-Cigarette Regulation: Public-Place Ban, Advertising Limits, Flavour Controls
Spain is advancing a 2025 Anti-Tobacco Law to align e-cigs with tobacco, tighten public-use/advertising/flavour rules, study phasing out disposables; cannabinoid, nicotine-free vapes are rising.
Oct.21 by 2FIRSTS.ai
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.
Sep.09